NXGM yields 1000000.00% · ABBV yields 3.06%● Live data
📍 NXGM pulled ahead of the other in Year 1
Combined, NXGM + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXGM + ABBV for your $10,000?
NexGen Mining, Inc., a junior mining company, engages in the exploration, mining, and production of precious metals. The company primarily explores for gold, silver, copper, lead, zinc, and other precious and base metals. It holds interests in the Old Dominion mine situated north of Reno, Nevada; the Koegel Hills property that consists of 10 unpatented claims encompassing 200 acres located in Mineral County, Nevada; the Four Mile Basin gold property, which comprises two unpatented claims consisting of 20 acres and is situated in Nye County, Nevada; the Gold Star property located in Mineral County, Nevada; and the Pyramid mine located Nevada, as well as in the Paradise Peak mine. NexGen Mining, Inc. was formerly known as Brilliant Sands Incorporated and changed its name to NexGen Mining, Inc. in January 2018. The company was incorporated in 1888 and is based in Reno, Nevada. NexGen Mining, Inc. is a former subsidiary of 1824455 Alberta Ltd.
Full NXGM Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.